Logo image
MTOR Inhibition Alters miRNA Profile in Cultured Bone Marrow Mesenchymal Stem Cells
Journal article   Open access   Peer reviewed

MTOR Inhibition Alters miRNA Profile in Cultured Bone Marrow Mesenchymal Stem Cells

Lisa Stukenborg, Manali Potnis and Christian Sell
Innovation in aging, v 5(Suppl 1), pp 667-667
17 Dec 2021
url
https://academic.oup.com/innovateage/article-pdf/5/Supplement_1/667/43186984/igab046.2516.pdfView
Published, Version of Record (VoR) Open
url
https://doi.org/10.1093/geroni/igab046.2516View
Published, Version of Record (VoR) Open

Abstract

Abstracts AcademicSubjects SOC02600
Progressive decline in adult stem cell function is a feature of aged tissues and contributes to multiple age-related diseases. Of particular interest are bone marrow mesenchymal stem cells, also known as bone marrow stromal cells (BMSCs), which are multipotent, and have significant therapeutic potential for age-related disease. BMSCs isolated from older individuals show decreased differentiation and characteristics of cell senescence. We and others find that inhibition of the mTOR pathway prevents senescence and extends BMSC proliferation. We have examined miRNA profiles in rapamycin-treated BMSCs to identify miRNAs that may be needed to maintain “stemness” and facilitate differentiation in this population in undifferentiated cell populations. The analysis reveals a distinct miRNA profile induced by rapamycin associated with enhanced differentiation capacity.

Metrics

12 Record Views

Details

Logo image